Announcements Trials

Browse Landscape

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1 Breast 1

Conditions

Early-onset Gastrointestinal Cancer 1

Interventions

Oxaliplatin 86 Bevacizumab 66 Capecitabine 65 Fluorouracil 48 tislelizumab 41 Gemcitabine 40 Drug Therapy 39 Leucovorin 38 sintilimab 35 Irinotecan 34 lenvatinib 27 Cisplatin 27 HMPL-013 25 S 1 (combination) 23 camrelizumab 22 Immune Checkpoint Inhibitors 21 irinotecan sucrosofate 20 apatinib 20 Surgical Procedures, Operative 20 Radiotherapy 20 Injections 20 130-nm albumin-bound paclitaxel 19 toripalimab 18 Paclitaxel 18 Folfox protocol 17 pembrolizumab 15 Immunotherapy 15 Cetuximab 15 Specimen Handling 14 regorafenib 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Demography × Gastrointestinal × Clear all

NCT07479472 2026-03-18

YOGICO

Gruppo Oncologico Italiano di Ricerca Clinica

Not yet recruiting

Gastrointestinal

Early-onset Gastrointestinal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡